Substitute estrogen therapy at post-varicotomy
- Authors: Riabtseva I.T.1, Shapovalova К.A.1
-
Affiliations:
- St. Petersburg State Medical University
- Issue: Vol 51, No 1 (2002)
- Pages: 64-67
- Section: Original Research
- URL: https://journals.rcsi.science/jowd/article/view/90020
- DOI: https://doi.org/10.17816/JOWD90020
- ID: 90020
Cite item
Abstract
The efficiency of preparation Divigel was specified in this work (1 mg of estradiol hemihydrate) within 12 months of use in women with post-varicotomy syndrome. After 6 months all patients-women have demonstrated the trust reduction Cuperman index, FSG level in blood serum and E2 concentration increase. After 6 months the osseous lost inhibition was noted, after 12 months the osseous mass increase was detected. Divigel therapy tells on positively on blood atherogenic profile.
Full Text
##article.viewOnOriginalSite##About the authors
I. T. Riabtseva
St. Petersburg State Medical University
Author for correspondence.
Email: info@eco-vector.com
Department of Obstetrics and Gynecology
Russian Federation, Saint PetersburgК. A. Shapovalova
St. Petersburg State Medical University
Email: info@eco-vector.com
Department of Obstetrics and Gynecology
Russian Federation, Saint Petersburg